Beta Drugs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
BETA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Beta Drugs Limited has informed the stock exchange that its trading window will be closed starting April 1, 2026. The closure will remain in effect until 48 hours after the company declares its audited financial results for the financial year ending March 31, 2026. The restriction applies to all directors, officers, designated employees, their immediate relatives, and others covered under the company's insider trading code. This is a standard regulatory compliance filing under SEBI's Prohibition of Insider Trading Regulations, 2015. The window closure typically signals that the company is in a quiet period ahead of its annual results announcement.
This is a routine compliance filing and does not directly affect shareholders. However, it indicates that the company's audited FY26 annual results are expected to be announced in the near future, which could be a catalyst for stock movement depending on the numbers.